M L 23 (Lisinopril 5 mg)
Pill imprint M L 23 has been identified as Lisinopril 5 mg.
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; migraine prevention; alport syndrome; coronary artery disease (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M L 23
M L 23
- 5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dihydrate dibasic
sodium lauryl sulfate
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|51079-0981||UDL Laboratories Inc|
|63874-0558||Altura Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about lisinopril
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.